沈婕

姓名:沈婕

职称:主任医师(三级)

一、教育经历

1.1990/09~1995/07天津医科大学,影像医学与核医学专业,本科

2.2000/09~2003/07天津医科大学,影像医学与核医学专业,硕士

3.2005/09~2011/07天津医科大学,影像医学与核医学专业,博士

4.2009/03~2010/06 德国罗斯托克大学,访问学者

二、工作经历

(写主要工作经历)

1995/07~2011/10天津市第一中心医院放射科

2011/11~今,天津市第一中心医院核医学科,科主任兼党支部书记

三、研究方向(包括承担课题项目)

分子影像诊断、核素治疗、体外分析。

在研课题:天津市科委科技支撑项目《PET/CT在动脉粥样硬化斑块诊断与心血管风险预测中的价值及诊疗方案研究》

四、学术兼职

天津市核医学基地毕业后质控专家组组长

天津市核医学质控中心副主任

中国非公立医疗机构协会核医学与分子影像专业委员会委员

天津市医学会核医学分会副主任委员

天津市核学会常务理事

天津医学影像技术研究会第八届副主任委员

天津市医师协会核医学医师分会常务委员

北京核学会与分子影像专业委员会委员

天津市抗癌协会肿瘤影像专业委员会委员

天津市医学会医疗事故、医疗损害、预防接种异常反应鉴定专家

天津市核与辐射项目环境影响评价审查专家

天津市科技专家

《国际放射医学核医学杂志》编委

《中国CTMRI杂志》编委


五、近五年发表的学术论文

1. MomoSun, JieShen. Combination of circulating tumor cells and 18F- FDG PET/CT for precision diagnosis in patients with non- small cell lung cancer. Cancer Medicine, 2024; 13:e70216.

2. Ruizhongyingshenjie. Worldwide research trends on bone metastases of lung cancer: a bibliometric analysis. Frontiers in Oncology, 2024,10

3. Xiaohuang Yang, Jie Shen. Risk factors and impact of occult and skip metastasis in early-stage oral tongue squamous cell carcinoma. Clinical Oral Investigations, 202428:510

4. YangYang, WeiYang, TianpengHu, MomoSun, JinWang, JieShen, EnciDing. Protective Effect of Biochanin A on Gamma Radiation Induced  Oxidative Stress, Antioxidant Status, Apoptotic, and DNAR epairing Molecules in Swiss Albino Mice. Cell Biochemistry and Function, 2024;42:e70005

5. Tianpeng Hujie shenMenglin ShaoXuemin FengDongyan LuEnci Ding. Prognostic value of pretreatment FDG PET-CT for short-termefficacy of radioactive iodine-125 seed implantation in patients with NSCLC. BRACHYTHERAPY, 2023,9,14:16

6. Xinbang JiangBoya MaMomo Sun, Chen Guo,Zhuang LiuYunzheng DuBiao WangNan LiMengya ChenYanjia ZhangJie ShenLailiang Ou. Dual Stealth Functional Immuno-magnetic Nanoparticles for HighPerformance Isolation of Circulating Tumor Cells. American Chemical Society, 202395(32):11885-11891

7. Jing Qiu , Yanhui Ru , Yang Gao  and Jie Shen. Experience in prenatal ultrasound diagnosis of fetal microtia and associated abnormalities. Frontiers in Medicine, 20237(11):01-06

8. Zhong ying Rui xue yinjie shenwei zheng. A retrospective study of clinical features and prognosis patients with Graves disease and ophthalmopathy. Nuclear Medicine Communications, 2022

9. Jia lijie shenlan qin. LBX2-AS1 ActivatesFSTL3 by Binding to Transcription Factor RARa to Foster ProliferationMigrationand Invasion of Thyroid Cancer. ORIGNAL RESEARCH, 2021,12,765033

10. Lichun Wanga, Jian Chen, Yamin Chai, Wenyan Hana , Jie Shen, Nan Lia , Jinyan Lua , Yunzheng Dua, Zhuang Liua , Yameng Yu, Jingzhe Dong and Lailiang Ou. Targeting regulation of the tumour microenvironment induces apoptosis of breast cancer cells by an affinity hemoperfusion adsorbent. Artificial Cells, Blood Substitutes, and Biotechnology, 202149(1)325-334

11. ENCIDING, DONGYAN LU , LIJUAN WEI , XUEMIN FENG , JIE SHEN and WENGUIXU.Predicting tumor recurrence using metabolic indices of 18FFDGPET/CT prior to orthotopic liver transplantation for hepatocellular carcinoma[J], ONCOLOGY LETTERS, 2020, 20, 1245-1255

12. SunmomoShenjie. Positron emission tomography/computed tomography findings of multiple cystic lymphangiomas in an adult: A case report[J], World Journal of Clinical Cases, 2020, 8(10), 1756-2065

六、荣誉和奖励

1.入选卫生健康行业高层次人才选拔培养工程—津门海河英才

2.入选2020年天津市创新人才推进计划重点领域创新团队

3.获天津市卫生局科技进步二等奖1项,科研成果4项、引进新技术及填补空白1项,申请专利1




七、联系方式

邮箱:shenjie_vip@126.com

电话:15620297083